A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01017952 · COMPLETED
Trial details
- NCT number
- NCT01017952
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-25
- Primary completion
- 2011-10-01
- Enrollment
- 1635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.